A 6-year-old boy from rural India presents with 3 weeks of fever, bone pain, and hepatosplenomegaly. CBC shows Hb 8.5 g/dL, WBC 120,000/µL with 70% blasts, platelets 45,000/µL. Flow cytometry confirms B-cell ALL. Uric acid is 9.2 mg/dL, creatinine 1.8 mg/dL (age-adjusted upper limit 0.8), LDH 2400 U/L. What is the most appropriate immediate management before starting chemotherapy?

Explanation

## Clinical Context This child has **high-risk B-ALL with tumor lysis syndrome (TLS) risk** — evidenced by: - Very high WBC (120,000/µL) - Elevated uric acid (9.2 mg/dL, normal <5.5) - Acute kidney injury (creatinine 1.8, age-adjusted ULN 0.8) - Elevated LDH (2400 U/L, indicates high tumor burden) ## Why Rasburicase Is Superior to Allopurinol **High-Yield:** In acute leukemia with high tumor burden and renal dysfunction, **rasburicase is the preferred urate-lowering agent**. | Feature | Rasburicase | Allopurinol | |---------|-------------|-------------| | **Mechanism** | Uricase enzyme; converts uric acid → allantoin (inactive) | Xanthine oxidase inhibitor; reduces uric acid production | | **Onset** | Rapid (within 30 min–4 hrs) | Slow (24–48 hrs) | | **Efficacy in TLS** | Superior; reduces uric acid by 90% | Moderate; takes days to be effective | | **Renal dysfunction** | Safe; works even in AKI | Contraindicated in severe renal failure (risk of xanthine precipitation) | | **Cost** | Higher | Lower | | **Use in India** | Available in tertiary centers | Widely used but slower | **Key Point:** Allopurinol is contraindicated or ineffective in acute kidney injury because it cannot prevent the acute surge of uric acid from tumor lysis, and it increases xanthine levels (which can precipitate in renal tubules). ## Correct Management Sequence 1. **Rasburicase 0.2 mg/kg IV** — rapidly converts existing uric acid to allantoin 2. **Aggressive IV hydration** — promotes urine output and flushes uric acid 3. **Monitor uric acid, creatinine, potassium, phosphate hourly** — detect worsening TLS 4. **Start chemotherapy only after uric acid normalizes** (<7 mg/dL) and creatinine begins to improve **Clinical Pearl:** In India, rasburicase availability may be limited in rural centers. If unavailable, allopurinol + hydration + frequent monitoring is the alternative, but rasburicase is the gold standard. ## Why Immediate Chemotherapy Is Dangerous Starting chemotherapy before controlling uric acid will cause: - Massive tumor lysis → hyperuricemia, hyperkalemia, hyperphosphatemia - Acute kidney injury progression - Cardiac arrhythmias (from K^+^ and phosphate) - Seizures (from hypocalcemia secondary to hyperphosphatemia) - Death ## Management Algorithm ```mermaid flowchart TD A[High-risk ALL suspected]:::outcome --> B{Assess TLS risk:<br/>WBC, LDH, uric acid,<br/>creatinine}:::decision B -->|High risk:<br/>WBC >100K, uric acid >8,<br/>AKI present| C[Rasburicase 0.2 mg/kg IV]:::action C --> D[IV hydration 3 L/m²/day]:::action D --> E[Monitor uric acid, K, PO4,<br/>creatinine q1h]:::action E --> F{Uric acid normalized<br/>& creatinine improving?}:::decision F -->|Yes| G[Start induction chemotherapy]:::action F -->|No| H[Continue hydration & monitoring]:::action H --> F G --> I[Continue TLS prophylaxis<br/>during induction]:::action ```